Upstate Active Clinical Trials

Study Title:

A Phase II Randomized Trial of Lenalidomide (NSC # 703813, IND # 70116) in Pediatric Patients with Recurrent, Refractory or Progressive Juvenile Pilocytic Astrocytoma and Optic Pathway Gliomas

What is the purpose of the study?

Treatment study to look at how well sunitinib malate works in treating younger patients with recurrent, refractory, or progressive malignant glioma or ependymoma.

Upstate Institutional Review Board (IRB) Number:

448389

Study/Protocol ID:

ACNS1022

Study Phase:

II

Patient Age Group:

Children

Principal Investigator:

Karol H Kerr, MD

ClinicalTrials.Gov ID:

NCT01553149

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Beatriz Kovar
Phone: 315-464-7232
Email: kovarb@upstate.edu

Return to Previous Page || Search Again